Image001 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 01)
Losartan Potassium Tablet, Film Coated
Product Images NDC 72789-179
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 72789-179). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image002 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 02)
This appears to be a chart or a graph related to a study of patients using either Atenolol or Losartan potassium. The chart shows the adjusted risk reduction percentage and the p-value for the primary endpoint. Additionally, the study timeline is represented in months up until 66 months. However, the chart seems incomplete or lacks context to fully evaluate the purpose of the study and its findings.*
Image003 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 03)
This is likely a graph or chart displaying the percentage of patients who had a fatal or non-fatal stroke while taking two different medications - Atenolol and Losartan potassium ot. The x-axis of the graph denotes study month, with data points at every 6-month interval up to 66 months. However, without more context or additional information, it is not possible to determine more specifically what this graph represents.*
Image004 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 04)
The provided text is a table showing the results of a study on the effectiveness of two medications (Losartan and Atenolol) for preventing primary composite stroke. The table displays the number of events and rates of stroke in different patient groups based on factors such as age, gender, race, diabetes, and history of cardiovascular disease. It also shows the hazard ratios and confidence intervals for each group to compare the effectiveness of the two medications.*
Image005 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 05)
The text indicates a report or a study discussing risk reduction of an event by 16.1%. The value of 'p' is given as 0.022. The remaining text seems to be a part of a table or graph, displaying the percentages of patients with an event, with 40 and 20 being possible values.*
72789179 Label (72789179)
This is a description of a medication named Losartan Potassium USP in tablet form. The tablets come in a bottle of 90 and each tablet contains 50 mg of the active ingredient, Losartan Potassium USP. The tablets have a shelf life until September 2022 and should be taken as advised. The medication is produced by a pharmaceutical company based in Oklahoma City. The label advises the user to contact a doctor if side effects occur and provides the FDA hotline for reporting side effects. The text also includes information about the lot and reorder number. The description does not include information on the medication's purpose or indications.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
